Description
Description
Lenvakast-10mg
Composition: Lenvatinib 10mg
Therapeutic Class: Antineoplastic
Aprazer’s Lenvakast: Globally Prescribed and Trusted
Aprazer Healthcare is the leading global pharmaceutical company that manufactures a range of oncology care therapeutics.
- • WHO–GMP certified, Affordable oncology Medicines
- • Reaching the global markets, Aprazer Healthcare products are available worldwide.
- • Africa, South America, Southeast Asia, CIS countries.
What is Lenvakast?
Lenvakast is lenvatinib, which is used to treat several advanced-stage or metastatic cancers.
Uses of Lenvakast
- • Advanced Kidney Cancer
- • Radioactive Iodine-refractory Differentiated Thyroid Cancer
- • Advanced Hepatocellular Carcinoma
- • Endometrial Carcinoma
How does Lenvakast work?
- • It is a multiple tyrosine kinase inhibitor
- • It blocks several kinase enzymes
- • Inhibits new blood vessel formation in cancer cells
- • Cause cancer cells to starve and die.
Common Side Effects Include
- • High BP
- • Tiredness
- • Diarrhea
- • Nausea
- • Loss of appetite
- • Weight decline
- • Hand and foot syndrome
- • Pain in muscles and joints
Serious Side Effects
These are dose-dependent side effects that can be managed by supportive care.
- • Dizziness, seizures, and confusion.
- • Stroke or heart failure.
- • Elevated liver enzymes, acute liver failure.
- • GIT perforations
- • Internal bleeding
- • Thrombosis
Precautions
To be cautiously used in patients with:
- • Heart disease
- • Renal disorder
- • Liver disorder
Contraindications
- • Not to be used if any previous allergy or hypersensitivity to lenvatinib or any excipients.
- • Breastfeeding mothers
- • Pregnant women
Warning
To be used under medical prescription only.
Important Safety and Monitoring Information
Regular monitoring of the liver function, cardiac functions, blood pressure, neurological condition, and renal function.
